Partner Article

Cignpost Diagnostics partners with LumiraDx to deliver gold standard Covid-19 test results within minutes

Leading health and diagnostic company, Cignpost Diagnostics, has signed a partnership with LumiraDx The deal will see LumiraDx’s rapid-result testing technology used by Cignpost for COVID testing across its corporate client base, specifically those in the elite sport and film and TV production sectors.

The collaboration will further bolster Cignpost’s rapid testing capabilities for both rapid antigen and gold-standard PCR methodologies. The LumiraDx SARS-CoV-2 RNA STAR Complete utilises a single-step method for RT-PCR instruments with results available in 20 minutes. The LumiraDx SARS-CoV-2 Antigen Test uses microfluidic technology and detects nucleocapsid protein from a nasal swab and presents results in under 12 minutes, making it one of the fastest and most sensitive antigen tests commercially available. Both tests have achieved US Food and Drug Administration (FDA) Emergency Use Authorization, CE Marking, and have been validated by Coronavirus Test Device Approvals (CTDA) and received UK Medicines and Healthcare products Regulatory Agency (MHRA) approval.

During the pandemic, Cignpost has advised and provided its cutting-edge diagnostic services to organisations across a range of sectors, including elite sports, film and TV production, defence, and financial services. Cignpost’s consumer division, ExpressTest, with 37 testing centres across the UK is the country’s largest Covid test provider.

Nick Markham, Co-founder, Cignpost Diagnostics, said, “Cignpost has a reputation for providing consumers with best-in-class testing resources and this partnership with LumiraDx only elevates the standard of our offering. We are committed to help power the economy’s recovery through the provision of high-quality testing services, to ensure businesses protect their employees’ health and maintain productivity. This collaboration will also open up LumiraDx’s broad diagnostics solutions and allow Cignpost to offer comprehensive health and wellbeing solutions to both its consumer and corporate clientele.”

David Walton, LumiraDx Chief Commercial Officer, said, “We are thrilled to be working with Cignpost Diagnostics and be a part of their cutting-edge testing offerings which have been utilised by some of the biggest names in the sport and entertainment industry. Cignpost has done an incredible job in establishing stringent testing protocols for clients, helping organisations maintain business continuity. Our Covid-19 testing options which combine speed with accuracy are a natural fit with the services that Cignpost already offers, and we look forward to a long and fruitful association.”

This was posted in Bdaily's Members' News section by Lucie Hayes .